AKT1 and cancer: Kaempferol inhibits various cancer cells by arresting cell cycle at the G2/M phase, targeting several signaling pathways (MAPK/ERK and PI3K/AKT) that are essential for the survival of cancer cells and modulating expression of epithelial-mesenchymal transition (EMT)-related markers.